News
DGX
166.85
-0.69%
-1.16
What 9 Analyst Ratings Have To Say About Quest Diagnostics
Benzinga · 22m ago
Quest Diagnostics Is Maintained at Outperform by Baird
Dow Jones · 4h ago
Baird Maintains Outperform on Quest Diagnostics, Raises Price Target to $191
Benzinga · 4h ago
Quest Diagnostics (NYSE:DGX) Will Pay A Larger Dividend Than Last Year At $0.80
Simply Wall St · 8h ago
Stocks Jump as Fed Backs Rate-Cut Forecast
NASDAQ · 23h ago
Wednesday Sector Laggards: Healthcare, Consumer Products
NASDAQ · 1d ago
Tap Billion-Dollar AI Opportunity in Oncology: Stocks in the Spotlight
NASDAQ · 1d ago
Top 10 performing dividend picks according to SA metrics
Seeking Alpha · 1d ago
Stocks Rally as Fed Chair Powell Says the US Economy Remains Strong
Barchart · 1d ago
Quest Diagnostics on Pace for Largest Percent Decrease Since July 2024 -- Data Talk
Dow Jones · 1d ago
Quest Diagnostics falls on Q1 outlook headwinds, reaffirms FY guidance
Seeking Alpha · 1d ago
*Quest Diagnostics Sees Adjusted EPS Growing at 7%-9% Compound Annual Rate Beyond 2025 >DGX
Dow Jones · 1d ago
*Quest Diagnostics Sees Revenue Growing at 4%-5% Compound Annual Rate Beyond 2025 >DGX
Dow Jones · 1d ago
*Quest Diagnostics: Worse-Than-Expected 1Q Weather Will Create $25M Revenue Headwind >DGX
Dow Jones · 1d ago
*Quest Diagnostics: Worse-Than-Expected 1Q Weather Will Create 10c EPS Headwind >DGX
Dow Jones · 1d ago
Press Release: Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day
Dow Jones · 1d ago
*Quest Diagnostics Sees FY Rev $10.7B-$10.85B >DGX
Dow Jones · 1d ago
Press Release: Quest Diagnostics to Highlight -2-
Dow Jones · 1d ago
*Quest Diagnostics Sees FY Adj EPS $9.55-Adj EPS $9.80 >DGX
Dow Jones · 1d ago
*Quest Diagnostics Sees FY EPS $8.34-EPS $8.59 >DGX
Dow Jones · 1d ago
More
Webull provides a variety of real-time DGX stock news. You can receive the latest news about Quest Diagnostics Inc through multiple platforms. This information may help you make smarter investment decisions.
About DGX
More
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.